Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,461 JPY | -0.88% | +1.32% | -15.99% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
ETFs positioned on Fuji Pharma Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 19 M€ | +9.27% | ||
0.00% | 45 M€ | 0.00% | - | |
0.00% | 17 M€ | +15.30% | - | |
0.00% | 140,441 M€ | +17.96% | ||
0.00% | 63,295 M€ | +17.98% | - | |
0.00% | 20,360 M€ | +16.90% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.99% | 233M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- 4554 Stock
- Funds and ETFs Fuji Pharma Co., Ltd.